A detailed history of Simmons Bank transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Simmons Bank holds 39,220 shares of EW stock, worth $2.63 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
39,220
Previous 38,288 2.43%
Holding current value
$2.63 Million
Previous $3.66 Million 0.98%
% of portfolio
0.28%
Previous 0.28%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$84.3 - $94.31 $78,567 - $87,896
932 Added 2.43%
39,220 $3.62 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $166,551 - $219,405
2,296 Added 6.38%
38,288 $3.66 Million
Q4 2023

Feb 06, 2024

BUY
$61.71 - $77.76 $225,426 - $284,057
3,653 Added 11.3%
35,992 $2.74 Million
Q3 2023

Oct 26, 2023

BUY
$69.28 - $93.38 $27,227 - $36,698
393 Added 1.23%
32,339 $2.24 Million
Q2 2023

Aug 03, 2023

BUY
$81.41 - $94.33 $161,191 - $186,773
1,980 Added 6.61%
31,946 $3.01 Million
Q1 2023

Apr 28, 2023

BUY
$74.26 - $84.51 $385,186 - $438,353
5,187 Added 20.93%
29,966 $2.48 Million
Q4 2022

Feb 08, 2023

BUY
$68.3 - $87.44 $85,238 - $109,125
1,248 Added 5.3%
24,779 $1.85 Million
Q3 2022

Oct 27, 2022

BUY
$82.37 - $107.29 $40,031 - $52,142
486 Added 2.11%
23,531 $1.95 Million
Q2 2022

Jul 29, 2022

BUY
$86.5 - $128.27 $112,104 - $166,237
1,296 Added 5.96%
23,045 $2.19 Million
Q1 2022

Apr 21, 2022

BUY
$101.96 - $128.34 $81,568 - $102,672
800 Added 3.82%
21,749 $2.56 Million
Q4 2021

Jan 28, 2022

BUY
$106.37 - $130.68 $52,334 - $64,294
492 Added 2.41%
20,949 $2.71 Million
Q3 2021

Oct 26, 2021

BUY
$102.91 - $122.75 $7,512 - $8,960
73 Added 0.36%
20,457 $2.32 Million
Q2 2021

Aug 05, 2021

BUY
$83.84 - $104.76 $226,871 - $283,480
2,706 Added 15.31%
20,384 $2.11 Million
Q1 2021

May 06, 2021

BUY
$78.68 - $90.67 $469,326 - $540,846
5,965 Added 50.93%
17,678 $1.48 Million
Q4 2020

Feb 08, 2021

SELL
$71.69 - $91.23 $60,076 - $76,450
-838 Reduced 6.68%
11,713 $1.07 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $14,781 - $19,236
-220 Reduced 1.72%
12,551 $1 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $481,264 - $643,609
8,364 Added 189.79%
12,771 $883,000
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $52,410 - $81,000
1,000 Added 29.35%
4,407 $831,000
Q4 2019

Jan 31, 2020

SELL
$71.7 - $82.09 $10,109 - $11,574
-141 Reduced 3.97%
3,407 $794,000
Q3 2019

Nov 13, 2019

SELL
$61.55 - $75.43 $1,538 - $1,885
-25 Reduced 0.7%
3,548 $780,000
Q4 2018

Jan 24, 2019

SELL
$46.41 - $56.94 $3,248 - $3,985
-70 Reduced 1.92%
3,573 $547,000
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $4,570 - $5,803
-100 Reduced 2.67%
3,643 $634,000
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $4,245 - $5,130
-100 Reduced 2.6%
3,743 $545,000
Q4 2017

Feb 13, 2018

SELL
$33.79 - $39.39 $5,642 - $6,578
-167 Reduced 4.16%
3,843 $433,000
Q2 2017

Aug 15, 2017

BUY
N/A
4,010
4,010 $475,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Simmons Bank Portfolio

Follow Simmons Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simmons Bank, based on Form 13F filings with the SEC.

News

Stay updated on Simmons Bank with notifications on news.